185 related articles for article (PubMed ID: 18060781)
1. Prognostic factors in node negative premenopausal women treated with breast conserving therapy without adjuvant systemic therapy.
Budrukkar AN; Sarin R; Chinoy RF; Badwe R; Shrivastava SK; Dinshaw KA
Breast; 2008 Jun; 17(3):263-9. PubMed ID: 18060781
[TBL] [Abstract][Full Text] [Related]
2. Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial Hospital.
Dinshaw KA; Sarin R; Budrukkar AN; Shrivastava SK; Deshpande DD; Chinoy RF; Badwe R; Hawaldar R
J Surg Oncol; 2006 Aug; 94(2):105-13. PubMed ID: 16847919
[TBL] [Abstract][Full Text] [Related]
3. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA
J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205
[TBL] [Abstract][Full Text] [Related]
4. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
5. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy.
Dinshaw KA; Budrukkar AN; Chinoy RF; Sarin R; Badwe R; Hawaldar R; Shrivastava SK
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1132-41. PubMed ID: 15978744
[TBL] [Abstract][Full Text] [Related]
6. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
[TBL] [Abstract][Full Text] [Related]
7. Does lymphovascular invasion predict regional nodal failure in breast cancer patients with zero to three positive lymph nodes treated with conserving surgery and radiotherapy? Implications for regional radiation.
Boutrus R; Abi-Raad R; Niemierko A; Brachtel EF; Rizk L; Kelada A; Taghian AG
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):793-8. PubMed ID: 20171799
[TBL] [Abstract][Full Text] [Related]
8. Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer patients with extracapsular invasion of axillary lymph node metastases?
Gruber G; Berclaz G; Altermatt HJ; Greiner RH
Strahlenther Onkol; 2003 Oct; 179(10):661-6. PubMed ID: 14566473
[TBL] [Abstract][Full Text] [Related]
9. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
[TBL] [Abstract][Full Text] [Related]
10. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger.
Floyd SR; Buchholz TA; Haffty BG; Goldberg S; Niemierko A; Raad RA; Oswald MJ; Sullivan T; Strom EA; Powell SN; Katz A; Taghian AG
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):358-64. PubMed ID: 16887288
[TBL] [Abstract][Full Text] [Related]
11. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
12. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.
Shen J; Hunt KK; Mirza NQ; Buchholz TA; Babiera GV; Kuerer HM; Bedrosian I; Ross MI; Ames FC; Feig BW; Singletary SE; Cristofanilli M; Meric-Bernstam F
Cancer; 2005 Aug; 104(3):479-90. PubMed ID: 15968686
[TBL] [Abstract][Full Text] [Related]
13. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
Meric F; Mirza NQ; Vlastos G; Buchholz TA; Kuerer HM; Babiera GV; Singletary SE; Ross MI; Ames FC; Feig BW; Krishnamurthy S; Perkins GH; McNeese MD; Strom EA; Valero V; Hunt KK
Cancer; 2003 Feb; 97(4):926-33. PubMed ID: 12569592
[TBL] [Abstract][Full Text] [Related]
14. Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy.
Budrukkar AN; Sarin R; Shrivastava SK; Deshpande DD; Dinshaw KA
Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):596-603. PubMed ID: 17706403
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors affecting survival and disease-free survival in lymph node-negative breast carcinomas.
Kuru B; Camlibel M; Gulcelik MA; Alagol H
J Surg Oncol; 2003 Jul; 83(3):167-72. PubMed ID: 12827686
[TBL] [Abstract][Full Text] [Related]
16. Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy.
Truong PT; Lesperance M; Culhaci A; Kader HA; Speers CH; Olivotto IA
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):175-82. PubMed ID: 15850919
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI.
Gruber G; Bonetti M; Nasi ML; Price KN; Castiglione-Gertsch M; Rudenstam CM; Holmberg SB; Lindtner J; Golouh R; Collins J; Crivellari D; Carbone A; Thürlimann B; Simoncini E; Fey MF; Gelber RD; Coates AS; Goldhirsch A;
J Clin Oncol; 2005 Oct; 23(28):7089-97. PubMed ID: 16192592
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence.
Kuo SH; Huang CS; Kuo WH; Cheng AL; Chang KJ; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1456-64. PubMed ID: 18692329
[TBL] [Abstract][Full Text] [Related]
19. Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment.
Livi L; Paiar F; Saieva C; Scoccianti S; Dicosmo D; Borghesi S; Agresti B; Nosi F; Orzalesi L; Santini R; Barca R; Biti GP
Radiother Oncol; 2007 Mar; 82(3):287-93. PubMed ID: 17188382
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
